10x Genomics, Inc. (BMV:TXG)
Mexico
· Delayed Price · Currency is MXN 332.00
+30.00 (9.93%)
At close: Feb 13, 2026
10x Genomics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | -43.54 | -182.63 | -255.1 | -166 | -58.22 | Upgrade
|
| Depreciation & Amortization | 43.82 | 43.71 | 43.62 | 33.01 | 28.25 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.81 | 3.05 | 9.85 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 0 | 1.72 | - | - | Upgrade
|
| Stock-Based Compensation | 109.12 | 140.75 | 166.95 | 136.85 | 95.96 | Upgrade
|
| Other Operating Activities | 0.91 | 0.52 | 0.43 | 1.96 | 0.08 | Upgrade
|
| Change in Accounts Receivable | 41.31 | 26.95 | -10.61 | -18.95 | -34.04 | Upgrade
|
| Change in Inventory | 27.95 | -9.78 | 7.87 | -21.19 | -30.13 | Upgrade
|
| Change in Accounts Payable | -2.13 | -3.35 | -6.02 | 5.86 | 11.08 | Upgrade
|
| Change in Unearned Revenue | 0.75 | 11.21 | 10.93 | 3.35 | 1.54 | Upgrade
|
| Change in Other Net Operating Assets | -42.95 | -23.78 | 15.17 | -8.49 | -35.89 | Upgrade
|
| Operating Cash Flow | 136.05 | 6.66 | -15.2 | -33.61 | -21.37 | Upgrade
|
| Operating Cash Flow Growth | 1941.57% | - | - | - | - | Upgrade
|
| Capital Expenditures | -5.94 | -12.39 | -48.6 | -131.66 | -101.28 | Upgrade
|
| Cash Acquisitions | -9.27 | - | - | -4 | -5.45 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -1 | -0.92 | - | - | Upgrade
|
| Investment in Securities | 1.77 | -19.24 | 183.02 | -215.23 | - | Upgrade
|
| Investing Cash Flow | -13.44 | -32.63 | 133.49 | -350.89 | -106.73 | Upgrade
|
| Long-Term Debt Repaid | - | - | -5.81 | -5.41 | -5.03 | Upgrade
|
| Total Debt Repaid | - | - | -5.81 | -5.41 | -5.03 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -5.81 | -5.41 | -5.03 | Upgrade
|
| Issuance of Common Stock | 6.8 | 10.91 | 19.48 | 21.23 | 40.33 | Upgrade
|
| Financing Cash Flow | 6.8 | 10.91 | 13.67 | 15.82 | 35.3 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.48 | -0.16 | -0.03 | -0.04 | 0.23 | Upgrade
|
| Net Cash Flow | 129.9 | -15.22 | 131.93 | -368.72 | -92.57 | Upgrade
|
| Free Cash Flow | 130.12 | -5.73 | -63.8 | -165.27 | -122.65 | Upgrade
|
| Free Cash Flow Margin | 20.24% | -0.94% | -10.31% | -32.00% | -25.01% | Upgrade
|
| Free Cash Flow Per Share | 1.04 | -0.05 | -0.55 | -1.45 | -1.11 | Upgrade
|
| Cash Interest Paid | - | - | 0.44 | 0.84 | 1.22 | Upgrade
|
| Cash Income Tax Paid | 2.39 | 5.64 | 4.93 | 3.93 | 8.66 | Upgrade
|
| Levered Free Cash Flow | 148.39 | 59.2 | 27.63 | -92.66 | -67.02 | Upgrade
|
| Unlevered Free Cash Flow | 148.39 | 59.2 | 27.65 | -92.36 | -66.48 | Upgrade
|
| Change in Working Capital | 24.94 | 1.25 | 17.34 | -39.42 | -87.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.